Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 625.00 | 354.63 | 494.00 | 691.00 | 0.7149 | 0.4112 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 625.00 | 354.63 | 392.00 | 691.00 | 0.5673 | 0.1097 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 625.00 | 354.63 | 610.00 | 691.00 | 0.8828 | 0.7570 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 561.00 | 691.00 | 0.8119 | 0.6106 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 653.00 | 691.00 | 0.9450 | 0.8858 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 514.00 | 691.00 | 0.7439 | 0.4706 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 625.00 | 354.63 | 679.00 | 691.00 | 0.9826 | 0.9639 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 626.00 | 691.00 | 0.9059 | 0.8049 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 2.00 | 691.00 | 0.0029 | -0.9954 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 3.00 | 691.00 | 0.0043 | -0.9930 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 628.00 | 691.00 | 0.9088 | 0.8109 | |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 622.00 | 691.00 | 0.9001 | 0.7929 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 625.00 | 354.63 | 751.00 | 691.00 | 1.0868 | 1.1807 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 502.00 | 691.00 | 0.7265 | 0.4349 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 625.00 | 354.63 | 639.00 | 691.00 | 0.9248 | 0.8439 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 625.00 | 354.63 | 354.00 | 691.00 | 0.5123 | -0.0018 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 625.00 | 354.63 | 767.00 | 691.00 | 1.1100 | 1.2290 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 625.00 | 354.63 | 451.00 | 691.00 | 0.6527 | 0.2838 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 827.00 | 691.00 | 1.1968 | 1.4105 | |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 458.00 | 691.00 | 0.6628 | 0.3045 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 625.00 | 354.63 | 471.00 | 691.00 | 0.6816 | 0.3430 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 786.00 | 691.00 | 1.1375 | 1.2864 | |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 625.00 | 354.63 | 477.00 | 691.00 | 0.6903 | 0.3608 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 625.00 | 354.63 | 843.00 | 691.00 | 1.2200 | 1.4590 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 625.00 | 354.63 | 349.00 | 691.00 | 0.5051 | -0.0165 |